BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27281077)

  • 1. The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease.
    Lee HW; Chung SH; Moon CM; Che X; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Medicine (Baltimore); 2016 Jun; 95(23):e3772. PubMed ID: 27281077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Polymorphisms of Interleukin-12B Gene and Susceptibility to Inflammatory Bowel Diseases: A Meta-analysis and Trial Sequential Analysis.
    Wang J; Liu H; Wang Y; Wu J; Wang C; Liu K; Qin Q
    Immunol Invest; 2021 Nov; 50(8):987-1006. PubMed ID: 33390082
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
    Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.
    Wu Z; Bi Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24130. PubMed ID: 34997981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.
    Vainer B; Nielsen OH; Hendel J; Horn T; Kirman I
    Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
    Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
    Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
    Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
    BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD99 refers to the activity of inflammatory bowel disease.
    Zhou G; Yang W; Yu L; Yu T; Liu Z
    Scand J Gastroenterol; 2017 Mar; 52(3):359-364. PubMed ID: 27866429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease.
    Chung SH; Lee HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Gut Liver; 2016 Jul; 10(4):574-80. PubMed ID: 26780089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Manolakis AC; Kapsoritakis AN; Georgoulias P; Tzavara C; Valotassiou V; Kapsoritaki A; Potamianos SP
    BMC Gastroenterol; 2010 Oct; 10():118. PubMed ID: 20946669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.